Professor Andrew Scott

Professor Andrew Scott

AM FAHMS

Director, Department of Molecular Imaging and Therapy; Head, Tumour Targeting Laboratory
Austin Health, ONJCRI
Fellow
Elected in 2017
VIC
Citation on election

Professor Andrew Scott has made significant contributions to science and medicine through the discovery of novel therapeutic antibodies that are impacting on cancer patient outcomes, and the development of evidence for positron emission tomography (PET) that has led to the approval of multiple Medicare clinical indications for accurately staging cancer patients. He has provided leadership of scientific and medical professional organisations and in public education. Professor Scott is recognised Internationally for his research and clinical expertise, and for advocacy of molecular imaging and therapy, reflected by his recent election as President of the World Federation of Nuclear Medicine and Biology.

 

Find out more

Whether you’re looking to nominate a colleague for an award, make a donation to the Academy or simply find out more about the work we do, research we advance and health policy advice we provide, sign up to our mailing list today.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.